By Barrett Seaman– When The Hudson Independent interviewed Regeneron’s President and Chief Scientific Officer George Yancopoulos last August, he predicted that the country’s inability to attain “herd immunity” against COVID-19 meant that there would be “a continuing reservoir for new variants to emerge.” With the sudden and dramatic invasion of the Omicron variant, we went back to the Tarrytown-based pharmaceutical company for an update. Herewith The Indy’s questions and Regeneron’s responses: THI: Our impression is that Omicron is significantly […]
The post Regeneron in the Age of Omicron appeared first on The Hudson Indy Westchester's Rivertowns News -.